Should I buy Ares Management (ARES) stock or is it too late?
⭐ The most reliable of them, either direction: Oppenheimer — 74% of its targets hit on this sector (441 calls tested). It aims for $151 (+6.0 %), call made on August 4, 2026, maturing on August 4, 2027 (24 d ago).
Firm-by-firm track record on Ares Management
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| B of A Securities | 86 % | +54.0 % | 7 | $197 +38% |
| BMO Capital | 100 % | +33.7 % | 6 | $134 -6% |
| Barclays | 83 % | +33.4 % | 23 | $139 -2% |
| UBS | 100 % | +29.5 % | 10 | $198 +39% |
| RBC Capital | 73 % | +20.0 % | 15 | $168 +18% |
| Wells Fargo | 62 % | +19.3 % | 24 | $202 +42% |
| JP Morgan | 62 % | +17.1 % | 8 | $153 +7% |
| Keefe, Bruyette & Woods | 60 % | +14.4 % | 10 | $189 +33% |
✅ Reasons to believe
- 78% of analysts rate it a buy (Buy consensus, 9 ratings) — a sign of market conviction.
- Pays a dividend (4.3% yield), raised for 6 years — regular income on top of potential upside.
⚠️ Reasons to hesitate
- Even the most reliable firm on ARES, BMO Capital (100% hit rate, 6 scored calls), only targets $134 (call made on August 3, 2026, maturing on August 3, 2027) (-6%) in its most recent call, and $156 (call made on October 3, 2025, maturing on October 3, 2026) (+10%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 9 ratings, 2 are neutral.
- Limited upside: the median target is only +7% from the current price.
- High valuation (P/E ~65): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on ARES
Median target $153 (+7%) · 9 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Ares Management now?
We won't decide for you. The facts: 78% of analysts rate it a buy, median target $153 (+7%), and BMO Capital (most reliable on ARES, 100%) targets $134. Weigh that against valuation (P/E ~65). This is not personalized advice.
Is it too late to invest in Ares Management?
Not according to analysts: the median target ($153) is still +7% above the current price ($142) (most reliable on ARES: BMO Capital, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Ares Management still worth investing in?
It depends on the gap between the price ($142) and its estimated value: analysts target $153 on median (+7%), with 78% buys (most reliable on ARES: BMO Capital, 100%). Cross-check with their real reliability on ARES and the cautions above. Information, not advice.
What's the main risk in buying ARES?
Even the most reliable firm on ARES, BMO Capital (100% hit rate, 6 scored calls), only targets $134 (call made on August 3, 2026, maturing on August 3, 2027) (-6%) in its most recent call, and $156 (call made on October 3, 2025, maturing on October 3, 2026) (+10%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Ares Management profile (consensus, analyst reliability, price target, performance).